Symbols / XCUR $4.19 -1.52% Exicure, Inc.
XCUR Chart
About
Exicure, Inc. does not have significant operations. Previously, the company focused on developing of nucleic acid therapies targeting ribonucleic acid against validated targets. Exicure, Inc. was founded in 2011 and is headquartered in Redwood City, California.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Biotechnology | Market Cap | 26.71M |
| Enterprise Value | 23.55M | Income | -4.95M | Sales | — |
| Book/sh | 0.62 | Cash/sh | 0.59 | Dividend Yield | — |
| Payout | 0.00% | Employees | — | IPO | — |
| P/E | — | Forward P/E | -5.44 | PEG | — |
| P/S | — | P/B | 6.80 | P/C | — |
| EV/EBITDA | -2.38 | EV/Sales | — | Quick Ratio | 0.98 |
| Current Ratio | 1.19 | Debt/Eq | 4.48 | LT Debt/Eq | — |
| EPS (ttm) | -0.79 | EPS next Y | -0.77 | EPS Growth | — |
| Revenue Growth | — | Earnings | 2022-08-15 17:00 | ROA | -43.46% |
| ROE | -92.47% | ROIC | — | Gross Margin | 0.00% |
| Oper. Margin | 0.00% | Profit Margin | 0.00% | Shs Outstand | 6.37M |
| Shs Float | 3.38M | Short Float | 1.93% | Short Ratio | 3.30 |
| Short Interest | — | 52W High | 13.74 | 52W Low | 3.10 |
| Beta | 4.19 | Avg Volume | 32.61K | Volume | 5.13K |
| Target Price | — | Recom | None | Prev Close | $4.25 |
| Price | $4.19 | Change | -1.52% |
Valuation Models
Price estimates from analyst targets and simple models.
Ratings
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2022-08-16 | main | Chardan Capital | — → Neutral | $2 |
- Exicure says its cash won't fund the next 12 months of operations - Stock Titan Wed, 25 Mar 2026 20
- Exicure, Inc. Reports 2025 Financial Results and Highlights Need for Additional Financing - Quiver Quantitative Wed, 25 Mar 2026 20
- Exicure HiTron Inc sells $3.3m in Exicure (XCUR) stock - Investing.com ue, 20 Jan 2026 08
- Volume Recap: Whats the beta of XCUR stock - 2026 Technical Patterns & Daily Oversold Stock Bounce Ideas - baoquankhu1.vn ue, 31 Mar 2026 23
- Exicure Announces Routine Board and Audit Committee Change - TipRanks Fri, 27 Mar 2026 21
- Exicure’s Risky Bet On Stem Cell Mobilization Pays Early Dividends - Finimize Mon, 08 Dec 2025 08
- Exicure Stock Rockets 70% on Clinical Trials, BlackRock Still In - Gotrade Wed, 31 Dec 2025 08
- Exicure (XCUR) director Sangjin Yeo to leave board and Audit Committee - Stock Titan Fri, 27 Mar 2026 20
- Sangsangin investment sells Exicure (XCUR) shares worth $3.77 million By Investing.com - Investing.com Wed, 10 Dec 2025 08
- Liquidity strain deepens as Exicure (NASDAQ: XCUR) posts 2025 results - Stock Titan Wed, 25 Mar 2026 20
- Exicure, Inc. Reports 2025 Financial Results and Announces Need for Additional Financing - Quiver Quantitative Wed, 25 Mar 2026 20
- Exicure stock soars after positive Phase 2 data for multiple myeloma drug - Investing.com Mon, 08 Dec 2025 08
- Exicure (Nasdaq: XCUR) reports positive Phase 2 burixafor data in multiple myeloma - Stock Titan Mon, 08 Dec 2025 08
- Insider Sale: 10% owner at $XCUR Sells 433,332 Shares | XCUR Stock News - Quiver Quantitative hu, 11 Dec 2025 08
- Exicure (NASDAQ: XCUR) flags going concern, legal and listing risks - Stock Titan Wed, 25 Mar 2026 20
Insider Transactions
Financials
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.00
-100.00%
|
0.50
|
0.00
-100.00%
|
28.83
|
| Operating Revenue |
|
0.00
-100.00%
|
0.50
|
0.00
-100.00%
|
28.83
|
| Operating Expense |
|
10.12
+85.67%
|
5.45
-58.52%
|
13.14
-57.15%
|
30.66
|
| Research And Development |
|
3.29
|
0.00
-100.00%
|
1.42
-92.80%
|
19.77
|
| Selling General And Administration |
|
6.83
+25.36%
|
5.45
-53.49%
|
11.71
+7.58%
|
10.89
|
| General And Administrative Expense |
|
6.83
+25.36%
|
5.45
-53.49%
|
11.71
+7.58%
|
10.89
|
| Other Gand A |
|
6.83
+25.36%
|
5.45
-53.49%
|
11.71
+7.58%
|
10.89
|
| Total Expenses |
|
10.12
+85.67%
|
5.45
-58.52%
|
13.14
-57.15%
|
30.66
|
| Operating Income |
|
-10.12
-104.43%
|
-4.95
+62.33%
|
-13.14
-617.53%
|
-1.83
|
| Total Operating Income As Reported |
|
-4.23
+65.39%
|
-12.23
+18.43%
|
-15.00
-719.01%
|
-1.83
|
| EBITDA |
|
-5.12
+42.16%
|
-8.85
+43.04%
|
-15.54
-20021.79%
|
0.08
|
| Normalized EBITDA |
|
-9.90
-400.15%
|
-1.98
+83.12%
|
-11.73
|
0.00
|
| Reconciled Depreciation |
|
0.46
-44.17%
|
0.82
-40.07%
|
1.38
-25.92%
|
1.86
|
| EBIT |
|
-5.58
+42.34%
|
-9.68
+42.80%
|
-16.91
-851.29%
|
-1.78
|
| Total Unusual Items |
|
4.78
+169.63%
|
-6.87
-80.53%
|
-3.81
-4979.49%
|
0.08
|
| Total Unusual Items Excluding Goodwill |
|
4.78
+169.63%
|
-6.87
-80.53%
|
-3.81
-4979.49%
|
0.08
|
| Special Income Charges |
|
4.68
+168.02%
|
-6.88
-270.08%
|
-1.86
|
0.00
|
| Other Special Charges |
|
-6.32
-647.19%
|
1.16
+23.13%
|
0.94
|
—
|
| Impairment Of Capital Assets |
|
0.00
-100.00%
|
5.72
|
0.00
|
—
|
| Restructuring And Mergern Acquisition |
|
1.55
|
0.00
|
—
|
—
|
| Net Income |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Pretax Income |
|
-5.58
+42.43%
|
-9.69
+42.69%
|
-16.91
-612.77%
|
-2.37
|
| Net Non Operating Interest Income Expense |
|
0.03
+380.00%
|
-0.01
-131.25%
|
0.03
+105.52%
|
-0.58
|
| Interest Expense Non Operating |
|
0.00
-94.44%
|
0.02
|
0.00
-100.00%
|
0.59
|
| Net Interest Income |
|
0.03
+380.00%
|
-0.01
-131.25%
|
0.03
+105.52%
|
-0.58
|
| Interest Expense |
|
0.00
-94.44%
|
0.02
|
0.00
-100.00%
|
0.59
|
| Interest Income Non Operating |
|
0.03
+262.50%
|
0.01
-75.00%
|
0.03
+113.33%
|
0.01
|
| Interest Income |
|
0.03
+262.50%
|
0.01
-75.00%
|
0.03
+113.33%
|
0.01
|
| Other Income Expense |
|
4.51
+195.25%
|
-4.73
-24.32%
|
-3.81
-10121.05%
|
0.04
|
| Other Non Operating Income Expenses |
|
-0.28
-112.87%
|
2.14
+106950.00%
|
-0.00
+95.00%
|
-0.04
|
| Gain On Sale Of Security |
|
0.11
+2040.00%
|
0.01
+100.26%
|
-1.95
-2597.44%
|
0.08
|
| Tax Provision |
|
-0.63
-8025.00%
|
0.01
|
0.00
-100.00%
|
0.21
|
| Tax Rate For Calcs |
|
0.00
-45.90%
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
0.54
+137.67%
|
-1.44
|
0.00
-100.00%
|
0.02
|
| Net Income Including Noncontrolling Interests |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Net Income From Continuing Operation Net Minority Interest |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Net Income From Continuing And Discontinued Operation |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Net Income Continuous Operations |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Normalized Income |
|
-9.19
-114.99%
|
-4.27
+67.40%
|
-13.11
-395.84%
|
-2.64
|
| Net Income Common Stockholders |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Diluted EPS |
|
-0.79
+83.37%
|
-4.75
+54.98%
|
-10.55
-276.79%
|
-2.80
|
| Basic EPS |
|
-0.79
+83.37%
|
-4.75
+54.98%
|
-10.55
-276.79%
|
-2.80
|
| Basic Average Shares |
|
6.30
+208.19%
|
2.04
+27.48%
|
1.60
+73.48%
|
0.92
|
| Diluted Average Shares |
|
6.30
+208.19%
|
2.04
+27.48%
|
1.60
+73.48%
|
0.92
|
| Diluted NI Availto Com Stockholders |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Gain On Sale Of PPE |
|
-0.09
|
0.00
+100.00%
|
-0.92
|
0.00
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Total Assets |
|
14.04
-6.74%
|
15.06
+30.02%
|
11.58
-50.36%
|
23.33
|
| Current Assets |
|
4.62
-66.18%
|
13.67
+575.54%
|
2.02
-79.86%
|
10.05
|
| Cash Cash Equivalents And Short Term Investments |
|
3.75
-70.05%
|
12.51
+1432.84%
|
0.82
-90.49%
|
8.58
|
| Cash And Cash Equivalents |
|
3.75
-70.05%
|
12.51
+1432.84%
|
0.82
-90.49%
|
8.58
|
| Other Short Term Investments |
|
—
|
—
|
—
|
0.00
|
| Receivables |
|
0.06
-89.61%
|
0.56
+123.20%
|
0.25
+125.23%
|
0.11
|
| Accounts Receivable |
|
—
|
—
|
—
|
—
|
| Other Receivables |
|
0.06
-89.61%
|
0.56
+123.20%
|
0.25
+125.23%
|
0.11
|
| Prepaid Assets |
|
0.59
+1.91%
|
0.57
-38.44%
|
0.93
+10.66%
|
0.84
|
| Other Current Assets |
|
0.23
+631.25%
|
0.03
+33.33%
|
0.02
-95.38%
|
0.52
|
| Total Non Current Assets |
|
9.42
+580.91%
|
1.38
-85.53%
|
9.56
-28.03%
|
13.28
|
| Net PPE |
|
0.31
+1076.92%
|
0.03
-99.60%
|
6.57
-32.86%
|
9.79
|
| Gross PPE |
|
0.50
+79.57%
|
0.28
-95.89%
|
6.80
-49.42%
|
13.44
|
| Accumulated Depreciation |
|
-0.20
+22.92%
|
-0.25
-12.44%
|
-0.23
+93.84%
|
-3.65
|
| Properties |
|
0.00
|
0.00
|
—
|
—
|
| Machinery Furniture Equipment |
|
0.06
+72.73%
|
0.03
+0.00%
|
0.03
-64.52%
|
0.09
|
| Construction In Progress |
|
—
|
—
|
—
|
0.00
|
| Other Properties |
|
0.41
+64.63%
|
0.25
-96.36%
|
6.76
-49.32%
|
13.34
|
| Leases |
|
0.04
|
0.00
|
—
|
—
|
| Goodwill And Other Intangible Assets |
|
8.18
|
0.00
|
—
|
—
|
| Goodwill |
|
4.40
|
0.00
|
—
|
—
|
| Other Intangible Assets |
|
3.78
|
—
|
—
|
—
|
| Non Current Prepaid Assets |
|
0.93
-31.61%
|
1.36
-23.98%
|
1.78
-20.74%
|
2.25
|
| Other Non Current Assets |
|
—
|
—
|
1.20
-3.07%
|
1.24
|
| Total Liabilities Net Minority Interest |
|
10.12
+22.10%
|
8.28
-3.10%
|
8.55
+1.70%
|
8.41
|
| Current Liabilities |
|
3.89
+26.60%
|
3.07
+22.35%
|
2.51
+53.14%
|
1.64
|
| Payables And Accrued Expenses |
|
3.71
+58.02%
|
2.35
+24.68%
|
1.88
+71.27%
|
1.10
|
| Payables |
|
1.69
+63.92%
|
1.03
-36.79%
|
1.63
+351.80%
|
0.36
|
| Accounts Payable |
|
1.69
+63.92%
|
1.03
-36.79%
|
1.63
+351.80%
|
0.36
|
| Current Accrued Expenses |
|
2.02
+53.41%
|
1.32
+420.95%
|
0.25
-65.76%
|
0.74
|
| Current Debt And Capital Lease Obligation |
|
0.18
-75.62%
|
0.72
+15.34%
|
0.63
+16.14%
|
0.54
|
| Current Debt |
|
—
|
—
|
—
|
—
|
| Other Current Borrowings |
|
—
|
—
|
—
|
—
|
| Current Capital Lease Obligation |
|
0.18
-75.62%
|
0.72
+15.34%
|
0.63
+16.14%
|
0.54
|
| Current Deferred Liabilities |
|
—
|
—
|
—
|
0.00
|
| Current Deferred Revenue |
|
—
|
—
|
—
|
0.00
|
| Total Non Current Liabilities Net Minority Interest |
|
6.23
+19.45%
|
5.21
-13.68%
|
6.04
-10.76%
|
6.77
|
| Long Term Debt And Capital Lease Obligation |
|
0.00
-100.00%
|
5.21
-13.68%
|
6.04
-10.76%
|
6.77
|
| Long Term Capital Lease Obligation |
|
0.00
-100.00%
|
5.21
-13.68%
|
6.04
-10.76%
|
6.77
|
| Non Current Deferred Liabilities |
|
0.42
|
0.00
|
—
|
0.00
|
| Non Current Deferred Revenue |
|
—
|
—
|
—
|
0.00
|
| Non Current Deferred Taxes Liabilities |
|
0.42
|
0.00
|
—
|
—
|
| Other Non Current Liabilities |
|
5.80
|
—
|
—
|
—
|
| Stockholders Equity |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Common Stock Equity |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Capital Stock |
|
0.00
+0.00%
|
0.00
|
0.00
|
0.00
|
| Common Stock |
|
0.00
+0.00%
|
0.00
|
0.00
|
0.00
|
| Preferred Stock |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Share Issued |
|
6.37
+5.76%
|
6.03
+248.34%
|
1.73
+74.20%
|
0.99
|
| Ordinary Shares Number |
|
6.37
+5.76%
|
6.03
+248.34%
|
1.73
+74.20%
|
0.99
|
| Additional Paid In Capital |
|
208.14
+1.02%
|
206.03
+6.98%
|
192.59
+2.68%
|
187.57
|
| Retained Earnings |
|
-204.21
-2.48%
|
-199.26
-5.12%
|
-189.56
-9.80%
|
-172.65
|
| Gains Losses Not Affecting Retained Earnings |
|
-0.00
|
0.00
|
0.00
|
0.00
|
| Other Equity Adjustments |
|
-0.00
|
—
|
—
|
—
|
| Total Equity Gross Minority Interest |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Total Capitalization |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Working Capital |
|
0.74
-93.06%
|
10.60
+2281.48%
|
-0.49
-105.78%
|
8.41
|
| Invested Capital |
|
3.93
-42.03%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Total Debt |
|
0.18
-97.03%
|
5.93
-10.95%
|
6.67
-8.77%
|
7.31
|
| Capital Lease Obligations |
|
0.18
-97.03%
|
5.93
-10.95%
|
6.67
-8.77%
|
7.31
|
| Net Tangible Assets |
|
-4.26
-162.86%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Tangible Book Value |
|
-4.26
-162.86%
|
6.77
+123.42%
|
3.03
-79.69%
|
14.92
|
| Line Item | Trend | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-8.55
-193.99%
|
-2.91
+71.90%
|
-10.36
+70.95%
|
-35.66
|
| Cash Flow From Continuing Operating Activities |
|
-8.55
-193.99%
|
-2.91
+71.90%
|
-10.36
+70.95%
|
-35.66
|
| Net Income From Continuing Operations |
|
-4.95
+49.02%
|
-9.70
+42.65%
|
-16.91
-555.07%
|
-2.58
|
| Depreciation Amortization Depletion |
|
0.46
-44.17%
|
0.82
-40.07%
|
1.38
-25.92%
|
1.86
|
| Depreciation |
|
0.46
-44.17%
|
0.82
-40.07%
|
1.38
-25.92%
|
1.86
|
| Depreciation And Amortization |
|
0.46
-44.17%
|
0.82
-40.07%
|
1.38
-25.92%
|
1.86
|
| Other Non Cash Items |
|
-4.77
-1071.25%
|
-0.41
|
—
|
0.52
|
| Stock Based Compensation |
|
0.00
-90.91%
|
0.02
-98.37%
|
1.35
-1.53%
|
1.37
|
| Asset Impairment Charge |
|
0.00
-100.00%
|
5.72
|
0.00
|
—
|
| Deferred Tax |
|
-0.63
|
0.00
|
—
|
—
|
| Deferred Income Tax |
|
-0.63
|
0.00
|
—
|
—
|
| Operating Gains Losses |
|
0.19
|
—
|
0.92
|
—
|
| Gain Loss On Investment Securities |
|
—
|
—
|
—
|
—
|
| Unrealized Gain Loss On Investment Securities |
|
—
|
0.00
-100.00%
|
2.00
|
0.00
|
| Gain Loss On Sale Of PPE |
|
0.09
|
0.00
-100.00%
|
0.92
|
0.00
|
| Change In Working Capital |
|
1.14
+80.98%
|
0.63
-30.96%
|
0.91
+102.48%
|
-36.81
|
| Change In Receivables |
|
1.34
+365.22%
|
-0.51
|
0.00
|
0.00
|
| Changes In Account Receivables |
|
1.34
+365.22%
|
-0.51
|
0.00
|
0.00
|
| Change In Prepaid Assets |
|
0.04
-96.01%
|
0.98
+33.29%
|
0.73
-75.98%
|
3.05
|
| Change In Payables And Accrued Expense |
|
-0.44
-144.28%
|
0.99
+13.32%
|
0.87
+110.57%
|
-8.24
|
| Change In Accrued Expense |
|
-0.61
-152.03%
|
1.18
+395.74%
|
-0.40
+92.31%
|
-5.19
|
| Change In Payable |
|
0.18
+191.71%
|
-0.19
-115.20%
|
1.27
+141.61%
|
-3.05
|
| Change In Account Payable |
|
0.18
+191.71%
|
-0.19
-115.20%
|
1.27
+141.61%
|
-3.05
|
| Change In Other Working Capital |
|
—
|
—
|
—
|
-28.83
|
| Change In Other Current Assets |
|
0.20
|
0.00
-100.00%
|
0.04
+101.76%
|
-2.17
|
| Change In Other Current Liabilities |
|
0.00
+100.00%
|
-0.83
-13.60%
|
-0.73
-14.29%
|
-0.64
|
| Investing Cash Flow |
|
-1.81
|
0.00
+100.00%
|
-1.08
-122.96%
|
4.70
|
| Cash Flow From Continuing Investing Activities |
|
-1.81
|
0.00
+100.00%
|
-1.08
-122.96%
|
4.70
|
| Net PPE Purchase And Sale |
|
0.04
|
0.00
-100.00%
|
0.92
+349.76%
|
0.20
|
| Sale Of PPE |
|
0.04
|
0.00
-100.00%
|
0.92
+349.76%
|
0.20
|
| Capital Expenditure |
|
-0.00
|
—
|
—
|
-0.01
|
| Capital Expenditure Reported |
|
-0.00
|
0.00
|
0.00
+100.00%
|
-0.01
|
| Net Investment Purchase And Sale |
|
—
|
0.00
+100.00%
|
-2.00
-144.43%
|
4.50
|
| Purchase Of Investment |
|
—
|
0.00
+100.00%
|
-2.00
-33.42%
|
-1.50
|
| Sale Of Investment |
|
—
|
—
|
0.00
-100.00%
|
6.00
|
| Net Business Purchase And Sale |
|
-1.85
|
0.00
|
—
|
—
|
| Purchase Of Business |
|
-2.32
|
0.00
|
—
|
—
|
| Gain Loss On Sale Of Business |
|
0.10
|
0.00
|
—
|
—
|
| Financing Cash Flow |
|
1.60
-88.06%
|
13.40
+264.78%
|
3.67
+218.33%
|
-3.10
|
| Cash Flow From Continuing Financing Activities |
|
1.60
-88.06%
|
13.40
+264.78%
|
3.67
+218.33%
|
-3.10
|
| Net Issuance Payments Of Debt |
|
0.00
-100.00%
|
1.00
|
0.00
+100.00%
|
-7.50
|
| Issuance Of Debt |
|
0.00
-100.00%
|
1.00
|
0.00
|
—
|
| Repayment Of Debt |
|
—
|
—
|
0.00
+100.00%
|
-7.50
|
| Long Term Debt Issuance |
|
—
|
—
|
—
|
—
|
| Long Term Debt Payments |
|
—
|
—
|
0.00
+100.00%
|
-7.50
|
| Net Long Term Debt Issuance |
|
—
|
—
|
0.00
+100.00%
|
-7.50
|
| Short Term Debt Issuance |
|
0.00
-100.00%
|
1.00
|
0.00
|
—
|
| Net Short Term Debt Issuance |
|
0.00
-100.00%
|
1.00
|
0.00
|
—
|
| Net Common Stock Issuance |
|
1.60
-87.10%
|
12.40
+127.98%
|
5.44
+7.94%
|
5.04
|
| Proceeds From Stock Option Exercised |
|
—
|
0.00
+100.00%
|
-0.80
-4310.53%
|
0.02
|
| Net Other Financing Charges |
|
—
|
—
|
-0.97
-45.48%
|
-0.66
|
| Changes In Cash |
|
-8.76
-183.51%
|
10.49
+235.19%
|
-7.76
+77.22%
|
-34.07
|
| Beginning Cash Position |
|
12.51
+520.44%
|
2.02
-79.38%
|
9.78
-77.70%
|
43.84
|
| End Cash Position |
|
3.75
-70.05%
|
12.51
+520.44%
|
2.02
-79.38%
|
9.78
|
| Free Cash Flow |
|
-8.56
-194.02%
|
-2.91
+71.90%
|
-10.36
+70.96%
|
-35.67
|
| Amortization Of Securities |
|
—
|
—
|
0.00
+100.00%
|
-0.00
|
| Common Stock Issuance |
|
1.60
-87.10%
|
12.40
+127.98%
|
5.44
+7.94%
|
5.04
|
| Issuance Of Capital Stock |
|
1.60
-87.10%
|
12.40
+127.98%
|
5.44
+7.94%
|
5.04
|
| Sale Of Business |
|
0.47
|
0.00
|
—
|
—
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-03-27 View
- 10-K2026-03-25 View
- 8-K2026-03-25 View
- 42026-02-19 View
- 8-K2026-02-17 View
- 8-K2026-02-10 View
- 8-K2026-01-22 View
- 42026-01-21 View
- 42026-01-20 View
- 42026-01-08 View
- 42025-12-10 View
- 42025-11-19 View
- 8-K2025-11-17 View
- 8-K2025-11-10 View
- 10-Q2025-11-07 View
- 8-K2025-11-07 View
- 8-K2025-09-09 View
- 42025-08-20 View
- 10-Q2025-08-08 View
- 8-K2025-08-08 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|